M Fiege - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

M Fiege

Showing results (21-30 of 30) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 30 results.

Naunyn-Schmiedeberg'S Archives of Pharmacology|November 7, 1999

5-HT2 receptor antagonist-mediated inhibition of halothane-induced contractures in skeletal muscle specimens from malignant hyperthermia susceptible patientsF Wappler, J Scholz, M Fiege, et al.

Anesthesiology|June 9, 1999

4-chloro-m-cresol is a trigger of malignant hyperthermia in susceptible swineF Wappler, J Scholz, M Fiege, et al.

Acta Anaesthesiologica Scandinavica|January 9, 1998

Attenuation of serotonin-induced contractures in skeletal muscle from malignant hyperthermia-susceptible patients with dantroleneF Wappler, J Scholz, V von Richthofen, et al.

Anesthesiology|February 15, 2001

Rhabdomyolysis following cardiopulmonary bypass and treatment with enoximone in a patient susceptible to malignant hyperthermiaF C Riess, M Fiege, S Moshar, et al.

Anesthesiology|January 3, 2001

Evidence for susceptibility to malignant hyperthermia in patients with exercise-induced rhabdomyolysisF Wappler, M Fiege, M Steinfath, et al.

Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS|August 5, 1998

[Incidence of disposition for malignant hyperthermia in patients with neuromuscular diseases]F Wappler, J Scholz, V von Richthofen, et al.

European Journal of Anaesthesiology|May 10, 2002

In vitro effects of 4-chloro-3-ethylphenol in skeletal muscle preparations from malignant hyperthermia susceptible and normal swineM U Gerbershagen, F Wappler, M Fiege, et al.

British Journal of Anaesthesia|July 25, 2003

Effects of a 5HT(2) receptor agonist on anaesthetized pigs susceptible to malignant hyperthermiaM U Gerbershagen, F Wappler, M Fiege, et al.

Anesthesia and Analgesia|January 7, 2000

A multicenter study of 4-chloro-m-cresol for diagnosing malignant hyperthermia susceptibilityC P Baur, L Bellon, P Felleiter, et al.

European Journal of Anaesthesiology|July 30, 2003

Multicentre evaluation of in vitro contracture testing with bolus administration of 4-chloro-m-cresol for diagnosis of malignant hyperthermia susceptibilityF Wappler, M Anetseder, C P Baur, et al.

Pageof 3

Search research articles

Showing results (21-30 of 30) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 30 results.

Naunyn-Schmiedeberg'S Archives of Pharmacology|November 7, 1999

5-HT2 receptor antagonist-mediated inhibition of halothane-induced contractures in skeletal muscle specimens from malignant hyperthermia susceptible patientsF Wappler, J Scholz, M Fiege, et al.

Anesthesiology|June 9, 1999

4-chloro-m-cresol is a trigger of malignant hyperthermia in susceptible swineF Wappler, J Scholz, M Fiege, et al.

Acta Anaesthesiologica Scandinavica|January 9, 1998

Attenuation of serotonin-induced contractures in skeletal muscle from malignant hyperthermia-susceptible patients with dantroleneF Wappler, J Scholz, V von Richthofen, et al.

Anesthesiology|February 15, 2001

Rhabdomyolysis following cardiopulmonary bypass and treatment with enoximone in a patient susceptible to malignant hyperthermiaF C Riess, M Fiege, S Moshar, et al.

Anesthesiology|January 3, 2001

Evidence for susceptibility to malignant hyperthermia in patients with exercise-induced rhabdomyolysisF Wappler, M Fiege, M Steinfath, et al.

Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS|August 5, 1998

[Incidence of disposition for malignant hyperthermia in patients with neuromuscular diseases]F Wappler, J Scholz, V von Richthofen, et al.

European Journal of Anaesthesiology|May 10, 2002

In vitro effects of 4-chloro-3-ethylphenol in skeletal muscle preparations from malignant hyperthermia susceptible and normal swineM U Gerbershagen, F Wappler, M Fiege, et al.

British Journal of Anaesthesia|July 25, 2003

Effects of a 5HT(2) receptor agonist on anaesthetized pigs susceptible to malignant hyperthermiaM U Gerbershagen, F Wappler, M Fiege, et al.

Anesthesia and Analgesia|January 7, 2000

A multicenter study of 4-chloro-m-cresol for diagnosing malignant hyperthermia susceptibilityC P Baur, L Bellon, P Felleiter, et al.

European Journal of Anaesthesiology|July 30, 2003

Multicentre evaluation of in vitro contracture testing with bolus administration of 4-chloro-m-cresol for diagnosis of malignant hyperthermia susceptibilityF Wappler, M Anetseder, C P Baur, et al.

Pageof 3